{"id":372819,"title":"Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T17:53:08.459000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-implementation-establishment-licensing-requirements-atypical-active-pharmaceutical-ingredients.html","snippet":"Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients This notice has previously undergone consultation. For more information visit Consultation Summary: Notice to Stakeholders - Implementation of…","rawSnapshotUrl":"/api/snapshots/raw/372819","browseUrl":"https://replay.healtharchive.ca/job-6/20260411175308/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-implementation-establishment-licensing-requirements-atypical-active-pharmaceutical-ingredients.html#ha_snapshot=372819","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}